Thomas Cueni has led IFPMA since 2017, during which time he has been instrumental in establishing cross-sectoral programmes designed to tackle the biggest global health challenges. This includes establishing the $1 billion AMR Action Fund to support the development of new antibiotics; serving as chair of the AMR Alliance; and being the industry’s representative on the Access to COVID-19 Tools Accelerator. Thomas began his career as a journalist, as London correspondent for the Basler Zeitung and Der Bund, before serving as a Swiss diplomat in Paris (OECD) and Vienna (IAEA, UNIDO). Thomas has a master’s degree in economics from the University of Basel and another in politics from the London School of Economics. He also studied at the Geneva Graduate Institute for International Studies.